We serve Chemical Name:benzimidazole carboxylic acid CAS:2849-93-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:benzimidazole carboxylic acid
CAS.NO:2849-93-6
Synonyms:1H-Benzimidazole-2-carboxylic acid;benzimidazole carboxylic acid;MFCD00721565;1H-benzimidazole-2-carboxylicacid;2-Benzimidazolecarboxylic acid
Molecular Formula:C8H6N2O2
Molecular Weight:162.145
HS Code:2933990090
Physical and Chemical Properties:
Melting point:169ºC
Boiling point:444.0±28.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.743
PSA:65.98000
Exact Mass:162.042923
LogP:1.06
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1H-Benzimidazole-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Benzimidazolecarboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,benzimidazole carboxylic acid Use and application,MFCD00721565 technical grade,usp/ep/jp grade.
Related News: It’s the first confirmed Wuhan coronavirus death from outside of mainland China, and brings the total toll to 305. benzimidazole carboxylic acid manufacturer The FDA approval allows Biogen to sell its product over several years – with forecasts for potential annual sales reaching as high $10 billion to $50 billion – until the company completes a required follow-up study. benzimidazole carboxylic acid supplier The FDA approval allows Biogen to sell its product over several years – with forecasts for potential annual sales reaching as high $10 billion to $50 billion – until the company completes a required follow-up study. benzimidazole carboxylic acid vendor The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route. benzimidazole carboxylic acid factory The FDA approval allows Biogen to sell its product over several years – with forecasts for potential annual sales reaching as high $10 billion to $50 billion – until the company completes a required follow-up study.
